Privia Health Group, Inc. (PRVA) stock
PRVANasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3060% above fair value
$24.55+0.88 (+3.72%)
Close on Nov 13, 2026Market cap $3.14BP/E 94.4Yield –
Privia Health price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Privia Health's price to sales ratio was 1.3× on Nov 11, 2026, against 1.5× a year earlier. Over the last 5 years it ranged from 1.1× to 3.7×, with a median of 1.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | −0.1 |
| 2025 | Dec 31, 2025 | 1.4× | +0.1 |
| 2024 | Dec 31, 2024 | 1.4× | −0.4 |
| 2023 | Dec 29, 2023 | 1.7× | −0.3 |
| 2022 | Dec 30, 2022 | 2.0× | −1.0 |
| 2021 | Dec 31, 2021 | 3.0× | – |
See a number that looks wrong?